Table 3.
EGD | Colonoscopy | |||
---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | |
Age | ||||
50–59 | 1.0 | -- | 1.0 | -- |
60–69 | 1.12 (0.86–1.45) | 0.41 | 1.44 (1.22–1.71) | <0.001 |
70+ | 1.35 (1.01–1.80) | 0.04 | 2.22 (1.86–2.65) | <0.001 |
Gender | ||||
Female | 1.48 (1.16–1.90) | 0.002 | 1.69 (1.45–1.97) | <0.001 |
Male | 1.0 | -- | 1.0 | -- |
Any anti-hypertensive | 0.72 (0.57–0.90) | 0.005 | 0.90 (0.76–1.04) | 0.14 |
Olmesartan | 1.99 (0.79–5.00) | 0.14 | 0.63 (0.23–1.74) | 0.37 |
Any ARB | 0.73 (0.49–1.09) | 0.12 | 1.17 (0.92–1.49) | 0.20 |
Any ACEI | 0.67 (0.50–0.92) | 0.01 | 0.89 (0.73–1.08) | 0.23 |
HCTZ/Chlorthalidone | 0.87 (0.58–1.30) | 0.49 | 0.66 (0.51–0.84) | <0.001 |
Beta Blocker | 1.07 (0.80–1.43) | 0.66 | 1.11 (0.93–1.33) | 0.25 |
Calcium Channel Blocker | 0.61 (0.38–0.98) | 0.04 | 0.97 (0.75–1.27) | 0.84 |
Exposures meeting statistical significance are shown in bold.